MiR‐30a Attenuates Immunosuppressive Functions of IL‐1β‐elicited Mesenchymal Stem Cells Via Targeting TAB3

Erling Hu,Liang Ding,Huishuang Miao,Fei Liu,Dan Liu,Huan Dou,Yayi Hou
DOI: https://doi.org/10.1016/j.febslet.2015.11.001
2015-01-01
FEBS Letters
Abstract:Mesenchymal stem cells (MSCs) possess the ability to modulate the immune response, and their abnormalities are related to several diseases. We previously reported that miR‐30a expression significantly increased in the maternal–fetal interface during preeclampsia (PE), but the effects of miR‐30a on the immunoregulatory characteristics of MSCs are unclear. In this study, we determined that miR‐30a over‐expression inhibited the IL‐1β‐elicited activation of the nuclear factor κB (NF‐κB) and JNK signaling pathways and the production of IL‐6, cyclooxygenase 2 (COX2) and IL‐8 by targeting transforming growth factor‐β‐activated kinase 1 binding protein 3 (TAB3) in MSCs. Moreover, the over‐expression of miR‐30a also impaired MSCs’ anti‐inflammatory effects on macrophages. These data demonstrated that miR‐30a in MSCs may participate in the immune dysregulation of the maternal–fetal interface during PE.
What problem does this paper attempt to address?